Jeff Olson is listed as an executive officer, director, and promoter on 5 SEC Form D filings by 4 issuers between Aug 2013 and Jul 2025: Prescient Ridge Fund, LLC (Chicago, IL — pooled investment fund — 2013; $67.9M reported sold to 139 investors), RevOpsis Therapeutics, Inc. (Springfield, IL — biotechnology — 2022; $7.9M reported sold to 36 investors), RevOpsis Holdings LLC (Tampa, FL — biotechnology — 2025; $1 reported sold to 66 investors) and RevOpsis Therapeutics Corp (Springfield, IL — biotechnology — 2022; 4 investors reported).
What this means A repeat sponsor — 4 separate companies raised money with this person listed as executive officer, director, and promoter, over about 12 years. Across those companies the filings report $75.8M sold in total.
3 of the issuers belong to the sponsor group Revopsis Therapeutics (3 issuers, $575K reported sold, 2022–2025).
What this means A sponsor group is one team that sets up a new company for each deal. Revopsis Therapeutics has 3 companies on file and $575K reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 9 bankruptcy cases matching the name listed in Key records below.
What this means 9 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 5 public filings for Jeff Olson and found 8 differences, 3 worth asking the sponsor about: Form D filed 105 days after the first sale; Form D filed 129 days after the first sale; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.